Latest Security News

5E Advanced Materials reports progress on its California boron project with a new feasibility study and equity raises, while highlighting ongoing funding uncertainties.

ResMed Inc has updated the foreign exchange rate for its upcoming dividend payable to ASX CDI holders, impacting the Australian dollar amount investors will receive.

Warriedar Resources Limited’s shares will be suspended from trading following court approval of Capricorn Metals’ acquisition scheme, marking a significant consolidation in Western Australia’s gold mining sector.

Platinum Capital Limited has secured an ASX waiver to extend the initial term of its new investment management agreement with L1 Capital to 10 years, pending shareholder approval at the upcoming AGM.

Robex Resources Inc. reported a mixed Q3 2025 with higher gold revenues offset by net losses, while progressing its Kiniéro gold project and announcing a merger with Predictive Discovery Limited.

Robex Resources reported a $16.5 million net loss in Q3 2025 and completed full drawdown of its $130 million project financing facility, progressing its Kiniéro gold project with a planned first gold pour in December. The company also announced a merger agreement with Predictive Discovery Limited, signaling strategic growth.

National Australia Bank updates its dividend details, confirming a fully franked payout of AUD 0.85 per share for the half-year ending September 2025, with flexible currency payment options for shareholders.

Develop Global Limited clarifies its director appointment and retirement process following an ASX compliance query, ensuring adherence to governance rules.

New Zealand Coastal Seafoods (ASX – NZS) marked a key milestone with its MV Bluefin's maiden Coral Sea fishing trip and is advancing plans for a $2 million capital raise amid strategic rebranding.

Sarama Resources has raised A$2.7 million to fund exploration at its Australian gold projects while progressing a significant arbitration claim against Burkina Faso for expropriation of its African permit.

Sarama Resources Ltd reported a $1.9 million loss for the first nine months of 2025 while securing A$2.7 million in equity funding and advancing a $242 million arbitration claim against Burkina Faso over mining permit expropriation.

Starpharma’s 2025 AGM highlighted breakthrough partnerships and clinical progress, positioning the biotech for growth. Key deals with Genentech and Radiopharm Theranostics underpin a promising pipeline and expanding revenue streams.